↓ Skip to main content

Cancer drugs with high repositioning potential for Alzheimer’s disease

Overview of attention for article published in Expert Opinion on Emerging Drugs, December 2023
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (80th percentile)

Mentioned by

news
1 news outlet

Readers on

mendeley
1 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Cancer drugs with high repositioning potential for Alzheimer’s disease
Published in
Expert Opinion on Emerging Drugs, December 2023
DOI 10.1080/14728214.2023.2296079
Pubmed ID
Authors

Jad Majeed, Marwan N. Sabbagh, Min H. Kang, J. Josh Lawrence, Kevin Pruitt, Sarah Bacus, Ellie Reyna, Maddy Brown, Boris Decourt

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 1 Mendeley reader of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 1 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 1 100%
Readers by discipline Count As %
Medicine and Dentistry 1 100%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 December 2023.
All research outputs
#4,744,322
of 25,059,640 outputs
Outputs from Expert Opinion on Emerging Drugs
#71
of 517 outputs
Outputs of similar age
#31,960
of 162,950 outputs
Outputs of similar age from Expert Opinion on Emerging Drugs
#1
of 3 outputs
Altmetric has tracked 25,059,640 research outputs across all sources so far. Compared to these this one has done well and is in the 79th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 517 research outputs from this source. They receive a mean Attention Score of 4.4. This one has done well, scoring higher than 85% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 162,950 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 80% of its contemporaries.
We're also able to compare this research output to 3 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them